ALK B
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
ALK is a global specialty pharmaceutical company focused on allergy and allergic asthma. It markets allergy immunotherapy treatments and other products and services for people with allergy and allergy doctors. Headquartered in Hørsholm, Denmark, ALK employs around 2,900 people worldwide and is listed on Nasdaq Copenhagen.
Read moreInterim report Q2'26
Interim report Q3'26
Revenue B
EBIT-% (adj.)
EPS (adj.)
Dividend %
Don't miss out - create an account and get all the possible benefits